Walter Plasencia

TL;DR: Treatment with low‐dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo, and there were no significant between‐group differences in the incidence of neonatal adverse outcomes or other adverse events.

TL;DR: In this article, a multivariate Gaussian model was fitted to the distribution of log multiples of the median (MoM) PI in the pre-eclampsia and unaffected groups.

TL;DR: The performance of screening for preterm and term pre‐eclampsia (PE) in the study population participating in the ASPRE (Combined Multimarker Screening and Randomized Patient Treatment with Aspirin for Evidence‐Based Preeclampsian Prevention) trial is examined.

TL;DR: To compare the performance of screening for pre‐eclampsia based on risk factors from medical history with the method proposed by The Fetal Medicine Foundation, which uses Bayes' theorem to combine the a‐priori risk from maternal factors, derived by a multivariable logistic model, with the results of various combinations of biophysical and biochemical measurements.

TL;DR: IUGR fetuses showed signs of cardiac dysfunction from early stages with the progression of fetal compromise, together with the appearance of biochemical signs of cell damage.